CPT Changes - New CPT Codes '2024

The summary of the New, Revised, and Deleted CPT code across all the sections of the CPT codes below,

• New – 230 Codes 
• Revised – 70 Codes 
• Deleted – 49 Codes

Presenting the significant 2024 updates related to Evaluation and Management, Here's a concise overview of the latest changes.

Evaluation & Management:

Time ranges eliminated from office/outpatient E/M codes.

Replaced with a single total time amount, set as the lowest number of minutes in the current range for each code.

New descriptors stress that practitioners must meet or exceed this specified time. Shared the required time spent details for each E&M code.

New CPT Codes

0420U Oncology (urothelial), mRNA expression profiling by real-time quantitative PCR of MDK, HOXA13, CDC2, IGFBP5, and CXCR2 in combination with droplet digital PCR (ddPCR) analysis of 6 single-nucleotide polymorphisms (SNPs) genes TERT and FGFR3, urine, algorithm reported as a risk score for urothelial carcinoma

0421U Oncology (colorectal) screening, quantitative real-time target and signal amplification of 8 RNA markers (GAPDH, SMAD4, ACY1, AREG, CDH1, KRAS, TNFRSF10B, EGLN2) and fecal hemoglobin, algorithm reported as a positive or negative for colorectal cancer risk

0422U Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating DNA analysis using next-generation sequencing, algorithm reported as a quantitative change from baseline, including specific alterations, if appropriate

0423U Psychiatry (eg, depression, anxiety), genomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition

0424U Oncology (prostate), exosome-based analysis of 53 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as no molecular evidence, low-, moderate- or elevated-risk of prostate cancer

0425U Genome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis, each comparator genome (eg, parents, siblings)

0426U Genome (eg, unexplained constitutional or heritable disorder or syndrome), ultra-rapid sequence analysis

0427U Monocyte distribution width, whole blood (List separately in addition to code for primary procedure)

0428U Oncology (breast), targeted hybrid-capture genomic sequence analysis panel, circulating tumor DNA (ctDNA) analysis of 56 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability, and tumor mutation burden

0429U Human papillomavirus (HPV), oropharyngeal swab, 14 high-risk types (ie, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68)

0430U Gastroenterology, malabsorption evaluation of alpha-1-antitrypsin, calprotectin, pancreatic elastase and reducing substances, feces, quantitative

0431U Glycine receptor alpha1 IgG, serum or cerebrospinal fluid (CSF), live cell-binding assay (LCBA), qualitative

0432U Kelch-like protein 11 (KLHL11) antibody, serum or cerebrospinal fluid (CSF), cell-binding assay, qualitative

0433U Oncology (prostate), 5 DNA regulatory markers by quantitative PCR, whole blood, algorithm, including prostate-specific antigen, reported as likelihood of cancer

0434U Drug metabolism (adverse drug reactions and drug response), genomic analysis panel, variant analysis of 25 genes with reported phenotypes

0435U Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported based on cytotoxicity percentage observed, minimum of 14 drugs or drug combinations

0436U Oncology (lung), plasma analysis of 388 proteins, using aptamer-based proteomics technology, predictive algorithm reported as clinical benefit from immune checkpoint inhibitor therapy

0437U Psychiatry (anxiety disorders), mRNA, gene expression profiling by RNA sequencing of 15 biomarkers, whole blood, algorithm reported as predictive risk score

0438U Drug metabolism (adverse drug reactions and drug response), buccal specimen, gene-drug interactions, variant analysis of 33 genes, including deletion/duplication analysis of CYP2D6, including reported phenotypes and impacted gene-drug interactions

0784T Insertion or replacement of percutaneous electrode array, spinal, with integrated neurostimulator, including imaging guidance, when performed

0785T Revision or removal of neurostimulator electrode array, spinal, with integrated neurostimulator

0786T Insertion or replacement of percutaneous electrode array, sacral, with integrated neurostimulator, including imaging guidance, when performed

0787T Revision or removal of neurostimulator electrode array, sacral, with integrated neurostimulator

0788T Electronic analysis with simple programming of implanted integrated neurostimulation system (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, spinal cord or sacral nerve, 1-3 parameters

0789T Electronic analysis with complex programming of implanted integrated neurostimulation system (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, spinal cord or sacral nerve, 4 or more parameters

0790T Revision (eg, augmentation, division of tether), replacement, or removal of thoracolumbar or lumbar vertebral body tethering, including thoracoscopy, when performed

0811T Remote multi-day complex uroflowmetry (eg, calibrated electronic equipment); set-up and patient education on use of equipment

0812T Remote multi-day complex uroflowmetry (eg, calibrated electronic equipment); device supply with automated report generation, up to 10 days

0813T Esophagogastroduodenoscopy, flexible, transoral, with volume adjustment of intragastric bariatric balloon

0814T Percutaneous injection of calcium-based biodegradable osteoconductive material, proximal femur, including imaging guidance, unilateral

0815T Ultrasound-based radiofrequency echographic multi-spectrometry (REMS), bone-density study and fracture-risk assessment, 1 or more sites, hips, pelvis, or spine

0816T Open insertion or replacement of integrated neurostimulation system for bladder dysfunction including electrode(s) (eg, array or leadless), and pulse generator or receiver, including analysis, programming, and imaging guidance, when performed, posterior tibial nerve; subcutaneous

0817T Open insertion or replacement of integrated neurostimulation system for bladder dysfunction including electrode(s) (eg, array or leadless), and pulse generator or receiver, including analysis, programming, and imaging guidance, when performed, posterior tibial nerve; subfascial

0818T Revision or removal of integrated neurostimulation system for bladder dysfunction, including analysis, programming, and imaging, when performed, posterior tibial nerve; subcutaneous

0819T Revision or removal of integrated neurostimulation system for bladder dysfunction, including analysis, programming, and imaging, when performed, posterior tibial nerve; subfascial

0820T Continuous in-person monitoring and intervention (eg, psychotherapy, crisis intervention), as needed, during psychedelic medication therapy; first physician or other qualified health care professional, each hour

0821T Continuous in-person monitoring and intervention (eg, psychotherapy, crisis intervention), as needed, during psychedelic medication therapy; second physician or other qualified health care professional, concurrent with first physician or other qualified health care professional, each hour (List separately in addition to code for primary procedure)

0822T Continuous in-person monitoring and intervention (eg, psychotherapy, crisis intervention), as needed, during psychedelic medication therapy; clinical staff under the direction of a physician or other qualified health care professional, concurrent with first physician or other qualified health care professional, each hour (List separately in addition to code for primary procedure)

0823T Transcatheter insertion of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography and/or right ventriculography, femoral venography, cavography) and device evaluation (eg, interrogation or programming), when performed

0824T Transcatheter removal of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography and/or right ventriculography, femoral venography, cavography), when performed

0825T Transcatheter removal and replacement of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography and/or right ventriculography, femoral venography, cavography) and device evaluation (eg, interrogation or programming), when performed

0826T Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional, leadless pacemaker system in single-cardiac chamber

0827T Digitization of glass microscope slides for cytopathology, fluids, washings, or brushings, except cervical or vaginal; smears with interpretation (List separately in addition to code for primary procedure)

0828T Digitization of glass microscope slides for cytopathology, fluids, washings, or brushings, except cervical or vaginal; simple filter method with interpretation (List separately in addition to code for primary procedure)

0829T Digitization of glass microscope slides for cytopathology, concentration technique, smears, and interpretation (eg, Saccomanno technique) (List separately in addition to code for primary procedure)

0830T Digitization of glass microscope slides for cytopathology, selective-cellular enhancement technique with interpretation (eg, liquid-based slide preparation method), except cervical or vaginal (List separately in addition to code for primary procedure)

0831T Digitization of glass microscope slides for cytopathology, cervical or vaginal (any reporting system), requiring interpretation by physician (List separately in addition to code for primary procedure)

0832T Digitization of glass microscope slides for cytopathology, smears, any other source; screening and interpretation (List separately in addition to code for primary procedure)

0833T Digitization of glass microscope slides for cytopathology, smears, any other source; preparation, screening and interpretation (List separately in addition to code for primary procedure)

0834T Digitization of glass microscope slides for cytopathology, smears, any other source; extended study involving over 5 slides and/or multiple stains (List separately in addition to code for primary procedure)

0835T Digitization of glass microscope slides for cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site (List separately in addition to code for primary procedure)

0836T Digitization of glass microscope slides for cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, each separate additional evaluation episode, same site (List separately in addition to code for primary procedure)

0837T Digitization of glass microscope slides for cytopathology, evaluation of fine needle aspirate; interpretation and report (List separately in addition to code for primary procedure)

0838T Digitization of glass microscope slides for consultation and report on referred slides prepared elsewhere (List separately in addition to code for primary procedure)

0839T Digitization of glass microscope slides for consultation and report on referred material requiring preparation of slides (List separately in addition to code for primary procedure)

0840T Digitization of glass microscope slides for consultation, comprehensive, with review of records and specimens, with report on referred material (List separately in addition to code for primary procedure)

0841T Digitization of glass microscope slides for pathology consultation during surgery; first tissue block, with frozen section(s), single specimen (List separately in addition to code for primary procedure)

0842T Digitization of glass microscope slides for pathology consultation during surgery; each additional tissue block with frozen section(s) (List separately in addition to code for primary procedure)

0843T Digitization of glass microscope slides for pathology consultation during surgery; cyt-ologic examination (eg, touch preparation, squash preparation), initial site (List separately in addition to code for primary procedure)

0844T Digitization of glass microscope slides for pathology consultation during surgery; cytologic examination (eg, touch preparation, squash preparation), each additional site (List separately in addition to code for primary procedure)

0845T Digitization of glass microscope slides for immunofluorescence, per specimen; initial single antibody stain procedure (List separately in addition to code for primary procedure)

0846T Digitization of glass microscope slides for immunofluorescence, per specimen; each additional single antibody stain procedure (List separately in addition to code for primary procedure)

0847T Digitization of glass microscope slides for examination and selection of retrieved archival (ie, previously diagnosed) tissue(s) for molecular analysis (eg, KRAS mutational analysis) (List separately in addition to code for primary procedure)

0848T Digitization of glass microscope slides for in situ hybridization (eg, FISH), per specimen; initial single probe stain procedure (List separately in addition to code for primary procedure)

0849T Digitization of glass microscope slides for in situ hybridization (eg, FISH), per specimen; each additional single probe stain procedure (List separately in addition to code for primary procedure)

0850T Digitization of glass microscope slides for in situ hybridization (eg, FISH), per specimen; each multiplex probe stain procedure (List separately in addition to code for primary procedure)

0851T Digitization of glass microscope slides for morphometric analysis, in situ hybridization (quantitative or semiquantitative), manual, per specimen; initial single probe stain procedure (List separately in addition to code for primary procedure)

0852T Digitization of glass microscope slides for morphometric analysis, in situ hybridization (quantitative or semiquantitative), manual, per specimen; each additional single probe stain procedure (List separately in addition to code for primary procedure)

0853T Digitization of glass microscope slides for morphometric analysis, in situ hybridization (quantitative or semiquantitative), manual, per specimen; each multiplex probe stain procedure (List separately in addition to code for primary procedure)

0854T Digitization of glass microscope slides for blood smear, peripheral, interpretation by physician with written report (List separately in addition to code for primary procedure)

0855T Digitization of glass microscope slides for bone marrow, smear interpretation (List separately in addition to code for primary procedure)

0856T Digitization of glass microscope slides for electron microscopy, diagnostic (List separately in addition to code for primary procedure)

0857T Opto-acoustic imaging, breast, unilateral, including axilla when performed, real-time with image documentation, augmentative analysis and report (List separately in addition to code for primary procedure)

0858T Externally applied transcranial magnetic stimulation with concomitant measurement of evoked cortical potentials with automated report

0859T Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), other than for screening for peripheral arterial disease, image acquisition, interpretation, and report; each additional anatomic site (List separately in addition to code for primary procedure)

0860T Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), for screening for peripheral arterial disease, including provocative maneuvers, image acquisition, interpretation, and report, one or both lower extremities

0861T Removal of pulse generator for wireless cardiac stimulator for left ventricular pacing; both components (battery and transmitter)

0862T Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; battery component only

0863T Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; transmitter component only

0864T Low-intensity extracorporeal shock wave therapy involving corpus cavernosum, low energy

0865T Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion identification, characterization, and quantification, with brain volume(s) quantification and/or severity score, when performed, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the brain during the same session

0866T Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion detection, characterization, and quantification, with brain volume(s) quantification and/or severity score, when performed, data preparation and transmission, interpretation and report, obtained with diagnostic MRI examination of the brain (List separately in addition to code for primary procedure)

22836 Anterior thoracic vertebral body tethering, including thoracoscopy, when performed; up to 7 vertebral segments

22837 Anterior thoracic vertebral body tethering, including thoracoscopy, when performed; 8 or more vertebral segments

22838 Revision (eg, augmentation, division of tether), replacement, or removal of thoracic vertebral body tethering, including thoracoscopy, when performed

27278 Arthrodesis, sacroiliac joint, percutaneous, with image guidance, including placement of intra-articular implant(s) (eg, bone allograft[s], synthetic device[s]), without placement of transfixation device

31242 Nasal/sinus endoscopy, surgical; with destruction by radiofrequency ablation, posterior nasal nerve

31243 Nasal/sinus endoscopy, surgical; with destruction by cryoablation, posterior nasal nerve

33276 Insertion of phrenic nerve stimulator system (pulse generator and stimulating lead[s]), including vessel catheterization, all imaging guidance, and pulse generator initial analysis with diagnostic mode activation, when performed

+33277 Insertion of phrenic nerve stimulator transvenous sensing lead (List separately in addition to code for primary procedure)

33278 Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; system, including pulse generator and lead(s)

33279 Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; transvenous stimulation or sensing lead(s) only

33280 Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator only

33281 Repositioning of phrenic nerve stimulator transvenous lead(s)

33287 Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator

33288 Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; transvenous stimulation or sensing lead(s)

52284 Cystourethroscopy, with mechanical urethral dilation and urethral therapeutic drug delivery by drug-coated balloon catheter for urethral stricture or stenosis, male, including fluoroscopy, when performed

58580 Transcervical ablation of uterine fibroid(s), including intraoperative ultrasound guidance and monitoring, radiofrequency

61889 Insertion of skull-mounted cranial neurostimulator pulse generator or receiver, including craniectomy or craniotomy, when performed, with direct or inductive coupling, with connection to depth and/or cortical strip electrode array(s)

61891 Revision or replacement of skull-mounted cranial neurostimulator pulse generator or receiver with connection to depth and/or cortical strip electrode array(s)

61892 Removal of skull-mounted cranial neurostimulator pulse generator or receiver with cranioplasty, when performed

64596 Insertion or replacement of percutaneous electrode array, peripheral nerve, with integrated neurostimulator, including imaging guidance, when performed; initial electrode array

+64597 Insertion or replacement of percutaneous electrode array, peripheral nerve, with integrated neurostimulator, including imaging guidance, when performed; each additional electrode array (List separately in addition to code for primary procedure)

64598 Revision or removal of neurostimulator electrode array, peripheral nerve, with integrated neurostimulator

67516 Suprachoroidal space injection of pharmacologic agent (separate procedure)

75580 Noninvasive estimate of coronary fractional flow reserve (FFR) derived from augmentative software analysis of the data set from a coronary computed tomography angiography, with interpretation and report by a physician or other qualified health care professional

76984 Ultrasound, intraoperative thoracic aorta (eg, epiaortic), diagnostic

76987 Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; including placement and manipulation of transducer, image acquisition, interpretation and report

76988 Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; placement, manipulation of transducer, and image acquisition only

76989 Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; interpretation and report only

81457 Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis, microsatellite instability

81458 Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis, copy number variants and microsatellite instability

81459 Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis or combined DNA and RNA analysis, copy number variants, microsatellite instability, tumor mutation burden, and rearrangements

81462 Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (eg, plasma), interrogation for sequence variants; DNA analysis or combined DNA and RNA analysis, copy number variants and rearrangements

81463 Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (eg, plasma), interrogation for sequence variants; DNA analysis, copy number variants, and microsatellite instability

81464 Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (eg, plasma), interrogation for sequence variants; DNA analysis or combined DNA and RNA analysis, copy number variants, microsatellite instability, tumor mutation burden, and rearrangements

81517 Liver disease, analysis of 3 biomarkers (hyaluronic acid [HA], procollagen III amino terminal peptide [PIIINP], tissue inhibitor of metalloproteinase 1 [TIMP-1]), using immunoassays, utilizing serum, prognostic algorithm reported as a risk score and risk of liver fibrosis and liver-related clinical events within 5 years

82166 Anti-mullerian hormone (AMH)

86041 Acetylcholine receptor (AChR); binding antibody

86042 Acetylcholine receptor (AChR); blocking antibody

86043 Acetylcholine receptor (AChR); modulating antibody

86366 Muscle-specific kinase (MuSK) antibody

87523 Infectious agent detection by nucleic acid (DNA or RNA); hepatitis D (delta), quantification, including reverse transcription, when performed

90589 Chikungunya virus vaccine, live attenuated, for intramuscular use

90623 Meningococcal pentavalent vaccine, conjugated Men A, C, W, Y- tetanus toxoid carrier, and Men B-FHbp, for intramuscular use

90679 Respiratory syncytial virus vaccine, preF, recombinant, subunit, adjuvanted, for intramuscular use

90380 Respiratory syncytial virus, monoclonal antibody, seasonal dose; 0.5 mL dosage, for intramuscular use

90381 Respiratory syncytial virus, monoclonal antibody, seasonal dose; 1 mL dosage, for intramuscular use 

90683 Respiratory syncytial virus vaccine, mRNA lipid nanoparticles,for intramuscular use 

92622 Diagnostic analysis, programming, and verification of an auditory osseointegrated sound processor, any type; first 60 minutes

+92623 Diagnostic analysis, programming, and verification of an auditory osseointegrated sound processor, any type; each additional 15 minutes (List separately in addition to code for primary procedure)

92972 Percutaneous transluminal coronary lithotripsy (List separately in addition to code for primary procedure)

93150 Therapy activation of implanted phrenic nerve stimulator system, including all interrogation and programming

93151 Interrogation and programming (minimum one parameter) of implanted phrenic nerve stimulator system

93152 Interrogation and programming of implanted phrenic nerve stimulator system during polysomnography

93153 Interrogation without programming of implanted phrenic nerve stimulator system

+93584 Venography for congenital heart defect(s), including catheter placement, and radiological supervision and interpretation; anomalous or persistent superior vena cava when it exists as a second contralateral superior vena cava, with native drainage to heart (List separately in addition to code for primary procedure)

+93585 Venography for congenital heart defect(s), including catheter placement, and radiological supervision and interpretation; azygos/hemiazygos venous system (List separately in addition to code for primary procedure)

+93586 Venography for congenital heart defect(s), including catheter placement, and radiological supervision and interpretation; coronary sinus (List separately in addition to code for primary procedure)

+93587 Venography for congenital heart defect(s), including catheter placement, and radiological supervision and interpretation; venovenous collaterals originating at or above the heart (eg, from innominate vein) (List separately in addition to code for primary procedure)

+93588 Venography for congenital heart defect(s), including catheter placement, and radiological supervision and interpretation; venovenous collaterals originating below the heart (eg, from the inferior vena cava) (List separately in addition to code for primary procedure)

+96547 Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) procedure, including separate incision(s) and closure, when performed; first 60 minutes (List separately in addition to code for primary procedure)

+96548 Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) procedure, including separate incision(s) and closure, when performed; each additional 30 minutes (List separately in addition to code for primary procedure)

97037 Application of a modality to 1 or more areas; low-level laser therapy (ie, nonthermal and non-ablative) for post-operative pain reduction

97550 Caregiver training in strategies and techniques to facilitate the patient’s functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face; initial 30 minutes

97551 Caregiver training in strategies and techniques to facilitate the patient’s functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face; each additional 15 minutes (List separately in addition to code for primary service)

97552 Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face with multiple sets of caregivers

+99459 Pelvic examination (List separately in addition to code for primary procedure)

Refer to Deleted CPT Codes

ICD 10 CM Codes Official Updates and Changes - 2024

There are 500+ code changes in 2024 including new, deleted, revised, and parent codes. These 2024 ICD-10-CM codes are to be used from the effective date of services from October 1, 2023, through September 30, 2024. 

New Codes  - 501 Additions

Deleted Codes - 25 Deletions

Revised Codes -  17 Revisions 

Converted to Parent Code - 25 Codes

New Codes

ICD Code Code Description

A41.54 Sepsis due to Acinetobacter baumannii

B96.83 Acinetobacter baumannii as the cause of diseases classified elsewhere

D13.91 Familial adenomatous polyposis

D13.99 Benign neoplasm of ill-defined sites within the digestive system

D48.110 Desmoid tumor of head and neck

D48.111 Desmoid tumor of chest wall

D48.112 Desmoid tumor, intrathoracic

D48.113 Desmoid tumor of abdominal wall

D48.114 Desmoid tumor, intraabdominal

D48.115 Desmoid tumor of upper extremity and shoulder girdle

D48.116 Desmoid tumor of lower extremity and pelvic girdle

D48.117 Desmoid tumor of back

D48.118 Desmoid tumor of other site

D48.119 Desmoid tumor of unspecified site

D48.19 Other specified neoplasm of uncertain behavior of connective and other soft tissue

D57.04 Hb-SS disease with dactylitis

D57.214 Sickle-cell/Hb-C disease with dactylitis

D57.414 Sickle-cell thalassemia, unspecified, with dactylitis

D57.434 Sickle-cell thalassemia beta zero with dactylitis

D57.454 Sickle-cell thalassemia beta plus with dactylitis

D57.814 Other sickle-cell disorders with dactylitis

D61.02 Shwachman-Diamond syndrome

D89.84 IgG4-related disease

E20.810 Autosomal dominant hypocalcemia

E20.811 Secondary hypoparathyroidism in diseases classified elsewhere

E20.812 Autoimmune hypoparathyroidism

E20.818 Other specified hypoparathyroidism due to impaired parathyroid hormone secretion

E20.819 Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified

E20.89 Other specified hypoparathyroidism

E74.05 Lysosome-associated membrane protein 2 [LAMP2] deficiency

E75.27 Pelizaeus-Merzbacher disease

E75.28 Canavan disease

E79.81 Aicardi-Goutieres syndrome

E79.82 Hereditary xanthinuria

E79.89 Other specified disorders of purine and pyrimidine metabolism

E88.43 Disorders of mitochondrial tRNA synthetases

E88.810 Metabolic syndrome

E88.811 Insulin resistance syndrome, Type A

E88.818 Other insulin resistance

E88.819 Insulin resistance, unspecified

E88.A Wasting disease (syndrome) due to underlying condition

G11.5 Hypomyelination - hypogonadotropic hypogonadism - hypodontia

G11.6 Leukodystrophy with vanishing white matter disease

G20.A1 Parkinson's disease without dyskinesia, without mention of fluctuations

G20.A2 Parkinson's disease without dyskinesia, with fluctuations

G20.B1 Parkinson's disease with dyskinesia, without mention of fluctuations

G20.B2 Parkinson's disease with dyskinesia, with fluctuations

G20.C Parkinsonism, unspecified

G23.3 Hypomyelination with atrophy of the basal ganglia and cerebellum

G31.80 Leukodystrophy, unspecified

G31.86 Alexander disease

G37.81 Myelin oligodendrocyte glycoprotein antibody disease

G37.89 Other specified demyelinating diseases of central nervous system

G40.C01 Lafora progressive myoclonus epilepsy, not intractable, with status epilepticus

G40.C09 Lafora progressive myoclonus epilepsy, not intractable, without status epilepticus

G40.C11 Lafora progressive myoclonus epilepsy, intractable, with status epilepticus

G40.C19 Lafora progressive myoclonus epilepsy, intractable, without status epilepticus

G43.E01 Chronic migraine with aura, not intractable, with status migrainosus

G43.E09 Chronic migraine with aura, not intractable, without status migrainosus

G43.E11 Chronic migraine with aura, intractable, with status migrainosus

G43.E19 Chronic migraine with aura, intractable, without status migrainosus

G90.B LMNB1-related autosomal dominant leukodystrophy

G93.42 Megaloencephalic leukoencephalopathy with subcortical cysts

G93.43 Leukoencephalopathy with calcifications and cysts

G93.44 Adult-onset leukodystrophy with axonal spheroids

H36.811 Nonproliferative sickle-cell retinopathy, right eye

H36.812 Nonproliferative sickle-cell retinopathy, left eye

H36.813 Nonproliferative sickle-cell retinopathy, bilateral

H36.819 Nonproliferative sickle-cell retinopathy, unspecified eye

H36.821 Proliferative sickle-cell retinopathy, right eye

H36.822 Proliferative sickle-cell retinopathy, left eye

H36.823 Proliferative sickle-cell retinopathy, bilateral

H36.829 Proliferative sickle-cell retinopathy, unspecified eye

H36.89 Other retinal disorders in diseases classified elsewhere

H50.621 Inferior oblique muscle entrapment, right eye

H50.622 Inferior oblique muscle entrapment, left eye

H50.629 Inferior oblique muscle entrapment, unspecified eye

H50.631 Inferior rectus muscle entrapment, right eye

H50.632 Inferior rectus muscle entrapment, left eye

H50.639 Inferior rectus muscle entrapment, unspecified eye

H50.641 Lateral rectus muscle entrapment, right eye

H50.642 Lateral rectus muscle entrapment, left eye

H50.649 Lateral rectus muscle entrapment, unspecified eye

H50.651 Medial rectus muscle entrapment, right eye

H50.652 Medial rectus muscle entrapment, left eye

H50.659 Medial rectus muscle entrapment, unspecified eye

H50.661 Superior oblique muscle entrapment, right eye

H50.662 Superior oblique muscle entrapment, left eye

H50.669 Superior oblique muscle entrapment, unspecified eye

H50.671 Superior rectus muscle entrapment, right eye

H50.672 Superior rectus muscle entrapment, left eye

H50.679 Superior rectus muscle entrapment, unspecified eye

H50.681 Extraocular muscle entrapment, unspecified, right eye

H50.682 Extraocular muscle entrapment, unspecified, left eye

H50.689 Extraocular muscle entrapment, unspecified, unspecified eye

H54.512 Low vision, right eye, category 2

H57.8A1 Foreign body sensation, right eye

H57.8A2 Foreign body sensation, left eye

H57.8A3 Foreign body sensation, bilateral eyes

H57.8A9 Foreign body sensation, unspecified eye

I1A Other hypertension

I1A.0 Resistant hypertension

I20.81 Angina pectoris with coronary microvascular dysfunction

I20.89 Other forms of angina pectoris

I21.B Myocardial infarction with coronary microvascular dysfunction

I24.81 Acute coronary microvascular dysfunction

I24.89 Other forms of acute ischemic heart disease

I25.85 Chronic coronary microvascular dysfunction

I47.10 Supraventricular tachycardia, unspecified

I47.11 Inappropriate sinus tachycardia, so stated

I47.19 Other supraventricular tachycardia

J15.61 Pneumonia due to Acinetobacter baumannii

J15.69 Pneumonia due to other Gram-negative bacteria

J44.81 Bronchiolitis obliterans and bronchiolitis obliterans syndrome

J44.89 Other specified chronic obstructive pulmonary disease

J4A.0 Restrictive allograft syndrome

J4A.8 Other chronic lung allograft dysfunction

J4A.9 Chronic lung allograft dysfunction, unspecified

K35.200 Acute appendicitis with generalized peritonitis, without perforation or abscess

K35.201 Acute appendicitis with generalized peritonitis, with perforation, without abscess

K35.209 Acute appendicitis with generalized peritonitis, without abscess, unspecified as to perforation

K35.210 Acute appendicitis with generalized peritonitis, without perforation, with abscess

K35.211 Acute appendicitis with generalized peritonitis, with perforation and abscess

K35.219 Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation

K63.8211 Small intestinal bacterial overgrowth, hydrogen-subtype

K63.8212 Small intestinal bacterial overgrowth, hydrogen sulfide-subtype

K63.8219 Small intestinal bacterial overgrowth, unspecified

K63.822 Small intestinal fungal overgrowth

K63.829 Intestinal methanogen overgrowth, unspecified

K68.2 Retroperitoneal fibrosis

K68.3 Retroperitoneal hematoma

K90.821 Short bowel syndrome with colon in continuity

K90.822 Short bowel syndrome without colon in continuity

K90.829 Short bowel syndrome, unspecified

K90.83 Intestinal failure

M80.0B1A Age-related osteoporosis with current pathological fracture, right pelvis, initial encounter for fracture

M80.0B1D Age-related osteoporosis with current pathological fracture, right pelvis, subsequent encounter for fracture with routine healing

M80.0B1G Age-related osteoporosis with current pathological fracture, right pelvis, subsequent encounter for fracture with delayed healing

M80.0B1K Age-related osteoporosis with current pathological fracture, right pelvis, subsequent encounter for fracture with nonunion

M80.0B1P Age-related osteoporosis with current pathological fracture, right pelvis, subsequent encounter for fracture with malunion

M80.0B1S Age-related osteoporosis with current pathological fracture, right pelvis, sequela

M80.0B2A Age-related osteoporosis with current pathological fracture, left pelvis, initial encounter for fracture

M80.0B2D Age-related osteoporosis with current pathological fracture, left pelvis, subsequent encounter for fracture with routine healing

M80.0B2G Age-related osteoporosis with current pathological fracture, left pelvis, subsequent encounter for fracture with delayed healing

M80.0B2K Age-related osteoporosis with current pathological fracture, left pelvis, subsequent encounter for fracture with nonunion

M80.0B2P Age-related osteoporosis with current pathological fracture, left pelvis, subsequent encounter for fracture with malunion

M80.0B2S Age-related osteoporosis with current pathological fracture, left pelvis, sequela

M80.0B9A Age-related osteoporosis with current pathological fracture, unspecified pelvis, initial encounter for fracture

M80.0B9D Age-related osteoporosis with current pathological fracture, unspecified pelvis, subsequent encounter for fracture with routine healing

M80.0B9G Age-related osteoporosis with current pathological fracture, unspecified pelvis, subsequent encounter for fracture with delayed healing

M80.0B9K Age-related osteoporosis with current pathological fracture, unspecified pelvis, subsequent encounter for fracture with nonunion

M80.0B9P Age-related osteoporosis with current pathological fracture, unspecified pelvis, subsequent encounter for fracture with malunion

M80.0B9S Age-related osteoporosis with current pathological fracture, unspecified pelvis, sequela

M80.8B1A Other osteoporosis with current pathological fracture, right pelvis, initial encounter for fracture

M80.8B1D Other osteoporosis with current pathological fracture, right pelvis, subsequent encounter for fracture with routine healing

M80.8B1G Other osteoporosis with current pathological fracture, right pelvis, subsequent encounter for fracture with delayed healing

M80.8B1K Other osteoporosis with current pathological fracture, right pelvis, subsequent encounter for fracture with nonunion

M80.8B1P Other osteoporosis with current pathological fracture, right pelvis, subsequent encounter for fracture with malunion

M80.8B1S Other osteoporosis with current pathological fracture, right pelvis, sequela

M80.8B2A Other osteoporosis with current pathological fracture, left pelvis, initial encounter for fracture

M80.8B2D Other osteoporosis with current pathological fracture, left pelvis, subsequent encounter for fracture with routine healing

M80.8B2G Other osteoporosis with current pathological fracture, left pelvis, subsequent encounter for fracture with delayed healing

M80.8B2K Other osteoporosis with current pathological fracture, left pelvis, subsequent encounter for fracture with nonunion

M80.8B2P Other osteoporosis with current pathological fracture, left pelvis, subsequent encounter for fracture with malunion

M80.8B2S Other osteoporosis with current pathological fracture, left pelvis, sequela

M80.8B9A Other osteoporosis with current pathological fracture, unspecified pelvis, initial encounter for fracture

M80.8B9D Other osteoporosis with current pathological fracture, unspecified pelvis, subsequent encounter for fracture with routine healing

M80.8B9G Other osteoporosis with current pathological fracture, unspecified pelvis, subsequent encounter for fracture with delayed healing

M80.8B9K Other osteoporosis with current pathological fracture, unspecified pelvis, subsequent encounter for fracture with nonunion

M80.8B9P Other osteoporosis with current pathological fracture, unspecified pelvis, subsequent encounter for fracture with malunion

M80.8B9S Other osteoporosis with current pathological fracture, unspecified pelvis, sequela

N02.B1 Recurrent and persistent immunoglobulin A nephropathy with glomerular lesion

N02.B2 Recurrent and persistent immunoglobulin A nephropathy with focal and segmental glomerular lesion

N02.B3 Recurrent and persistent immunoglobulin A nephropathy with diffuse membranoproliferative glomerulonephritis

N02.B4 Recurrent and persistent immunoglobulin A nephropathy with diffuse membranous glomerulonephritis

N02.B5 Recurrent and persistent immunoglobulin A nephropathy with diffuse mesangial proliferative glomerulonephritis

N02.B6 Recurrent and persistent immunoglobulin A nephropathy with diffuse mesangiocapillary glomerulonephritis

N02.B9 Other recurrent and persistent immunoglobulin A nephropathy

N04.20 Nephrotic syndrome with diffuse membranous glomerulonephritis, unspecified

N04.21 Primary membranous nephropathy with nephrotic syndrome

N04.22 Secondary membranous nephropathy with nephrotic syndrome

N04.29 Other nephrotic syndrome with diffuse membranous glomerulonephritis

N06.20 Isolated proteinuria with diffuse membranous glomerulonephritis, unspecified

N06.21 Primary membranous nephropathy with isolated proteinuria

N06.22 Secondary membranous nephropathy with isolated proteinuria

N06.29 Other isolated proteinuria with diffuse membranous glomerulonephritis

O26.641 Intrahepatic cholestasis of pregnancy, first trimester

O26.642 Intrahepatic cholestasis of pregnancy, second trimester

O26.643 Intrahepatic cholestasis of pregnancy, third trimester

O26.649 Intrahepatic cholestasis of pregnancy, unspecified trimester

O90.41 Hepatorenal syndrome following labor and delivery

O90.49 Other postpartum acute kidney failure

Q44.70 Other congenital malformation of liver, unspecified

Q44.71 Alagille syndrome

Q44.79 Other congenital malformations of liver

Q75.001 Craniosynostosis unspecified, unilateral

Q75.002 Craniosynostosis unspecified, bilateral

Q75.009 Craniosynostosis unspecified

Q75.01 Sagittal craniosynostosis

Q75.021 Coronal craniosynostosis unilateral

Q75.022 Coronal craniosynostosis bilateral

Q75.029 Coronal craniosynostosis unspecified

Q75.03 Metopic craniosynostosis

Q75.041 Lambdoid craniosynostosis, unilateral

Q75.042 Lambdoid craniosynostosis, bilateral

Q75.049 Lambdoid craniosynostosis, unspecified

Q75.051 Cloverleaf skull

Q75.052 Pansynostosis

Q75.058 Other multi-suture craniosynostosis

Q75.08 Other single-suture craniosynostosis

Q87.83 Bardet-Biedl syndrome

Q87.84 Laurence-Moon syndrome

Q87.85 MED13L syndrome

Q93.52 Phelan-McDermid syndrome

R09.A0 Foreign body sensation, unspecified

R09.A1 Foreign body sensation, nose

R09.A2 Foreign body sensation, throat

R09.A9 Foreign body sensation, other site

R40.2A Nontraumatic coma due to underlying condition

R92.30 Dense breasts, unspecified

R92.311 Mammographic fatty tissue density, right breast

R92.312 Mammographic fatty tissue density, left breast

R92.313 Mammographic fatty tissue density, bilateral breasts

R92.321 Mammographic fibroglandular density, right breast

R92.322 Mammographic fibroglandular density, left breast

R92.323 Mammographic fibroglandular density, bilateral breasts

R92.331 Mammographic heterogeneous density, right breast

R92.332 Mammographic heterogeneous density, left breast

R92.333 Mammographic heterogeneous density, bilateral breasts

R92.341 Mammographic extreme density, right breast

R92.342 Mammographic extreme density, left breast

R92.343 Mammographic extreme density, bilateral breasts

T56.821A Toxic effect of gadolinium, accidental (unintentional), initial encounter

T56.821D Toxic effect of gadolinium, accidental (unintentional), subsequent encounter

T56.821S Toxic effect of gadolinium, accidental (unintentional), sequela

T56.822A Toxic effect of gadolinium, intentional self-harm, initial encounter

T56.822D Toxic effect of gadolinium, intentional self-harm, subsequent encounter

T56.822S Toxic effect of gadolinium, intentional self-harm, sequela

T56.823A Toxic effect of gadolinium, assault, initial encounter

T56.823D Toxic effect of gadolinium, assault, subsequent encounter

T56.823S Toxic effect of gadolinium, assault, sequela

T56.824A Toxic effect of gadolinium, undetermined, initial encounter

T56.824D Toxic effect of gadolinium, undetermined, subsequent encounter

T56.824S Toxic effect of gadolinium, undetermined, sequela

W44.8XXA Other foreign body entering into or through a natural orifice, initial encounter

W44.8XXD Other foreign body entering into or through a natural orifice, subsequent encounter

W44.8XXS Other foreign body entering into or through a natural orifice, sequela

W44.9XXA Unspecified foreign body entering into or through a natural orifice, initial encounter

W44.9XXD Unspecified foreign body entering into or through a natural orifice, subsequent encounter

W44.9XXS Unspecified foreign body entering into or through a natural orifice, sequela

W44.A0XA Battery unspecified, entering into or through a natural orifice, initial encounter

W44.A0XD Battery unspecified, entering into or through a natural orifice, subsequent encounter

W44.A0XS Battery unspecified, entering into or through a natural orifice, sequela

W44.A1XA Button battery entering into or through a natural orifice, initial encounter

W44.A1XD Button battery entering into or through a natural orifice, subsequent encounter

W44.A1XS Button battery entering into or through a natural orifice, sequela

W44.A9XA Other batteries entering into or through a natural orifice, initial encounter

W44.A9XD Other batteries entering into or through a natural orifice, subsequent encounter

W44.A9XS Other batteries entering into or through a natural orifice, sequela

W44.B0XA Plastic object unspecified, entering into or through a natural orifice, initial encounter

W44.B0XD Plastic object unspecified, entering into or through a natural orifice, subsequent encounter

W44.B0XS Plastic object unspecified, entering into or through a natural orifice, sequela

W44.B1XA Plastic bead entering into or through a natural orifice, initial encounter

W44.B1XD Plastic bead entering into or through a natural orifice, subsequent encounter

W44.B1XS Plastic bead entering into or through a natural orifice, sequela

W44.B2XA Plastic coin entering into or through a natural orifice, initial encounter

W44.B2XD Plastic coin entering into or through a natural orifice, subsequent encounter

W44.B2XS Plastic coin entering into or through a natural orifice, sequela

W44.B3XA Plastic toy and toy part entering into or through a natural orifice, initial encounter

W44.B3XD Plastic toy and toy part entering into or through a natural orifice, subsequent encounter

W44.B3XS Plastic toy and toy part entering into or through a natural orifice, sequela

W44.B4XA Plastic jewelry entering into or through a natural orifice, initial encounter

W44.B4XD Plastic jewelry entering into or through a natural orifice, subsequent encounter

W44.B4XS Plastic jewelry entering into or through a natural orifice, sequela

W44.B5XA Plastic bottle entering into or through a natural orifice, initial encounter

W44.B5XD Plastic bottle entering into or through a natural orifice, subsequent encounter

W44.B5XS Plastic bottle entering into or through a natural orifice, sequela

W44.B9XA Other plastic object entering into or through a natural orifice, initial encounter

W44.B9XD Other plastic object entering into or through a natural orifice, subsequent encounter

W44.B9XS Other plastic object entering into or through a natural orifice, sequela

W44.C0XA Glass unspecified, entering into or through a natural orifice, initial encounter

W44.C0XD Glass unspecified, entering into or through a natural orifice, subsequent encounter

W44.C0XS Glass unspecified, entering into or through a natural orifice, sequela

W44.C1XA Sharp glass entering into or through a natural orifice, initial encounter

W44.C1XD Sharp glass entering into or through a natural orifice, subsequent encounter

W44.C1XS Sharp glass entering into or through a natural orifice, sequela

W44.C2XA Intact glass entering into or through a natural orifice, initial encounter

W44.C2XD Intact glass entering into or through a natural orifice, subsequent encounter

W44.C2XS Intact glass entering into or through a natural orifice, sequela

W44.D0XA Magnetic metal object unspecified, entering into or through a natural orifice, initial encounter

W44.D0XD Magnetic metal object unspecified, entering into or through a natural orifice, subsequent encounter

W44.D0XS Magnetic metal object unspecified, entering into or through a natural orifice, sequela

W44.D1XA Magnetic metal bead entering into or through a natural orifice, initial encounter

W44.D1XD Magnetic metal bead entering into or through a natural orifice, subsequent encounter

W44.D1XS Magnetic metal bead entering into or through a natural orifice, sequela

W44.D2XA Magnetic metal coin entering into or through a natural orifice, initial encounter

W44.D2XD Magnetic metal coin entering into or through a natural orifice, subsequent encounter

W44.D2XS Magnetic metal coin entering into or through a natural orifice, sequela

W44.D3XA Magnetic metal toy entering into or through a natural orifice, initial encounter

W44.D3XD Magnetic metal toy entering into or through a natural orifice, subsequent encounter

W44.D3XS Magnetic metal toy entering into or through a natural orifice, sequela

W44.D4XA Magnetic metal jewelry entering into or through a natural orifice, initial encounter

W44.D4XD Magnetic metal jewelry entering into or through a natural orifice, subsequent encounter

W44.D4XS Magnetic metal jewelry entering into or through a natural orifice, sequela

W44.D9XA Other magnetic metal objects entering into or through a natural orifice, initial encounter

W44.D9XD Other magnetic metal objects entering into or through a natural orifice, subsequent encounter

W44.D9XS Other magnetic metal objects entering into or through a natural orifice, sequela

W44.E0XA Non-magnetic metal object unspecified, entering into or through a natural orifice, initial encounter

W44.E0XD Non-magnetic metal object unspecified, entering into or through a natural orifice, subsequent encounter

W44.E0XS Non-magnetic metal object unspecified, entering into or through a natural orifice, sequela

W44.E1XA Non-magnetic metal bead entering into or through a natural orifice, initial encounter

W44.E1XD Non-magnetic metal bead entering into or through a natural orifice, subsequent encounter

W44.E1XS Non-magnetic metal bead entering into or through a natural orifice, sequela

W44.E2XA Non-magnetic metal coin entering into or through a natural orifice, initial encounter

W44.E2XD Non-magnetic metal coin entering into or through a natural orifice, subsequent encounter

W44.E2XS Non-magnetic metal coin entering into or through a natural orifice, sequela

W44.E3XA Non-magnetic metal toy entering into or through a natural orifice, initial encounter

W44.E3XD Non-magnetic metal toy entering into or through a natural orifice, subsequent encounter

W44.E3XS Non-magnetic metal toy entering into or through a natural orifice, sequela

W44.E4XA Non-magnetic metal jewelry entering into or through a natural orifice, initial encounter

W44.E4XD Non-magnetic metal jewelry entering into or through a natural orifice, subsequent encounter

W44.E4XS Non-magnetic metal jewelry entering into or through a natural orifice, sequela

W44.E9XA Other non-magnetic metal objects entering into or through a natural orifice, initial encounter

W44.E9XD Other non-magnetic metal objects entering into or through a natural orifice, subsequent encounter

W44.E9XS Other non-magnetic metal objects entering into or through a natural orifice, sequela

W44.F0XA Objects of natural or organic material unspecified, entering into or through a natural orifice, initial encounter

W44.F0XD Objects of natural or organic material unspecified, entering into or through a natural orifice, subsequent encounter

W44.F0XS Objects of natural or organic material unspecified, entering into or through a natural orifice, sequela

W44.F1XA Bezoar entering into or through a natural orifice, initial encounter

W44.F1XD Bezoar entering into or through a natural orifice, subsequent encounter

W44.F1XS Bezoar entering into or through a natural orifice, sequela

W44.F2XA Rubber band entering into or through a natural orifice, initial encounter

W44.F2XD Rubber band entering into or through a natural orifice, subsequent encounter

W44.F2XS Rubber band entering into or through a natural orifice, sequela

W44.F3XA Food entering into or through a natural orifice, initial encounter

W44.F3XD Food entering into or through a natural orifice, subsequent encounter

W44.F3XS Food entering into or through a natural orifice, sequela

W44.F4XA Insect entering into or through a natural orifice, initial encounter

W44.F4XD Insect entering into or through a natural orifice, subsequent encounter

W44.F4XS Insect entering into or through a natural orifice, sequela

W44.F9XA Other object of natural or organic material, entering into or through a natural orifice, initial encounter

W44.F9XD Other object of natural or organic material, entering into or through a natural orifice, subsequent encounter

W44.F9XS Other object of natural or organic material, entering into or through a natural orifice, sequela

W44.G0XA Other non-organic objects unspecified, entering into or through a natural orifice, initial encounter

W44.G0XD Other non-organic objects unspecified, entering into or through a natural orifice, subsequent encounter

W44.G0XS Other non-organic objects unspecified, entering into or through a natural orifice, sequela

W44.G1XA Audio device entering into or through a natural orifice, initial encounter

W44.G1XD Audio device entering into or through a natural orifice, subsequent encounter

W44.G1XS Audio device entering into or through a natural orifice, sequela

W44.G2XA Combination metal and plastic toy and toy part entering into or through natural orifice, initial encounter

W44.G2XD Combination metal and plastic toy and toy part entering into or through natural orifice, subsequent encounter

W44.G2XS Combination metal and plastic toy and toy part entering into or through natural orifice, sequela

W44.G3XA Combination metal and plastic jewelry entering into or through a natural orifice, initial encounter

W44.G3XD Combination metal and plastic jewelry entering into or through a natural orifice, subsequent encounter

W44.G3XS Combination metal and plastic jewelry entering into or through a natural orifice, sequela

W44.G9XA Other non-organic objects entering into or through a natural orifice, initial encounter

W44.G9XD Other non-organic objects entering into or through a natural orifice, subsequent encounter

W44.G9XS Other non-organic objects entering into or through a natural orifice, sequela

W44.H0XA Other sharp object unspecified, entering into or through a natural orifice, initial encounter

W44.H0XD Other sharp object unspecified, entering into or through a natural orifice, subsequent encounter

W44.H0XS Other sharp object unspecified, entering into or through a natural orifice, sequela

W44.H1XA Needle entering into or through a natural orifice, initial encounter

W44.H1XD Needle entering into or through a natural orifice, subsequent encounter

W44.H1XS Needle entering into or through a natural orifice, sequela

W44.H2XA Knife, sword or dagger entering into or through a natural orifice, initial encounter

W44.H2XD Knife, sword or dagger entering into or through a natural orifice, subsequent encounter

W44.H2XS Knife, sword or dagger entering into or through a natural orifice, sequela

Z02.84 Encounter for child welfare exam

Z05.81 Observation and evaluation of newborn for suspected condition related to home physiologic monitoring device ruled out

Z05.89 Observation and evaluation of newborn for other specified suspected condition ruled out

Z16.13 Resistance to carbapenem

Z22.340 Carrier of carbapenem-resistant Acinetobacter baumannii

Z22.341 Carrier of carbapenem-sensitive Acinetobacter baumannii

Z22.349 Carrier of Acinetobacter baumannii, unspecified

Z22.350 Carrier of carbapenem-resistant Enterobacterales

Z22.358 Carrier of other Enterobacterales

Z22.359 Carrier of Enterobacterales, unspecified

Z29.81 Encounter for HIV pre-exposure prophylaxis

Z29.89 Encounter for other specified prophylactic measures

Z62.23 Child in custody of non-parental relative

Z62.24 Child in custody of non-relative guardian

Z62.823 Parent-step child conflict

Z62.831 Non-parental relative-child conflict

Z62.832 Non-relative guardian-child conflict

Z62.833 Group home staff-child conflict

Z62.892 Runaway [from current living environment]

Z83.710 Family history of adenomatous and serrated polyps

Z83.711 Family history of hyperplastic colon polyps

Z83.718 Other family history of colon polyps

Z83.719 Family history of colon polyps, unspecified

Z91.85 Personal history of military service

Z91.A41 Caregiver's other noncompliance with patient's medication regimen due to financial hardship

Z91.A48 Caregiver's other noncompliance with patient's medication regimen for other reason

Z91.A51 Caregiver's noncompliance with patient's renal dialysis due to financial hardship

Z91.A58 Caregiver's noncompliance with patient's renal dialysis for other reason

Z91.A91 Caregiver's noncompliance with patient's other medical treatment and regimen due to financial hardship

Z91.A98 Caregiver's noncompliance with patient's other medical treatment and regimen for other reason

Revised Codes

ICD Code Code Description

H54.511 Low vision, right eye, category 1

I25.112 Atherosclerotic heart disease of native coronary artery with refractory angina pectoris

I71.51 Supraceliac aneurysm of the thoracoabdominal aorta, ruptured

I71.52 Paravisceral aneurysm of the thoracoabdominal aorta, ruptured

I71.61 Supraceliac aneurysm of the thoracoabdominal aorta, without rupture

I71.62 Paravisceral aneurysm of the thoracoabdominal aorta, without rupture

M41.12 Adolescent idiopathic scoliosis

N35.812 Other bulbous urethral stricture, male

P19.9 Metabolic acidemia in newborn, unspecified

Q85.81 PTEN hamartoma tumor syndrome

Q87.40 Marfan syndrome, unspecified

Q87.410 Marfan syndrome with aortic dilation

Q87.418 Marfan syndrome with other cardiovascular manifestations

Q87.42 Marfan syndrome with ocular manifestations

Q87.43 Marfan syndrome with skeletal manifestation

Converted to Parent Code

ICD Code Code Description

D13.9 Benign neoplasm of ill-defined sites within the digestive system

D48.1 Neoplasm of uncertain behavior of connective and other soft tissue

E20.8 Other hypoparathyroidism

E79.8 Other disorders of purine and pyrimidine metabolism

E88.81 Metabolic syndrome and other insulin resistance

G20 Parkinson's disease

G37.8 Other specified demyelinating diseases of central nervous system

H36 Retinal disorders in diseases classified elsewhere

I20.8 Other forms of angina pectoris

I24.8 Other forms of acute ischemic heart disease

I47.1 Supraventricular tachycardia

J15.6 Pneumonia due to other Gram-negative bacteria

K35.20 Acute appendicitis with generalized peritonitis, without abscess

K35.21 Acute appendicitis with generalized peritonitis, with abscess

N04.2 Nephrotic syndrome with diffuse membranous glomerulonephritis

N06.2 Isolated proteinuria with diffuse membranous glomerulonephritis

O90.4 Postpartum acute kidney failure

Q44.7 Other congenital malformations of liver

Q75.0 Craniosynostosis

Z05.8 Observation and evaluation of newborn for other specified suspected condition ruled out

Z29.8 Encounter for other specified prophylactic measures

Z83.71 Family history of colonic polyps

Z91.A4 Caregiver's other noncompliance with patient's medication regimen

Z91.A5 Caregiver's noncompliance with patient's renal dialysis

Z91.A9 Caregiver's noncompliance with patient's other medical treatment and regimen

Click HERE to refer to the summary of the ICD 10 CM changes in 2024

ICD 10 CM Official Updates and Changes - 2024 Summary

There are 500+ code changes in 2024 including new, deleted, revised, and parent codes. These 2024 ICD-10-CM codes are to be used from the effective date of services from October 1, 2023, through September 30, 2024. 

New Codes  - 501 Additions

Deleted Codes - 25 Deletions

Revised Codes -  17 Revisions 

Converted to Parent Code - 25 Codes

Summary of the changes and updates

The updates include new codes, revised codes & deletions in 17 different chapters of ICD-10-CM. Changes to the Index and other revisions are also included in the updates. 

The distribution of codes and a summary of selected conditions are listed below,

Chapter 1: Infectious and parasitic diseases – 2 codes for Acinetobacter baumannii sepsis or the cause of diseases classified elsewhere.

Chapter 2: Neoplasms – 13 codes, including 10 codes for desmoid tumors. Desmoid tumors are a rare type of tumor arising in deep connective and soft tissues and often have a variable and unpredictable course. Desmoid tumors do not metastasize and are not classified as malignant. They tend to be locally aggressive, infiltrative, and destructive. They may also be known as aggressive fibromatosis. Desmoid tumors can occur in any soft or connective tissue throughout the body, but are usually categorized into four general areas: abdominal wall; extremities/shoulder and pelvic girdles/chest wall; intraabdominal/retroperitoneal/pelvic cavity; head and neck/intrathoracic.

Chapter 3: Diseases of blood and blood-forming organs and disorders involving immune mechanism – 8 codes, including codes for Sickle-cell conditions with dactylitis. Dactylitis is a severe inflammation of the fingers and toes commonly seen in infants with sickle cell anemia.

Chapter 4: Endocrine, nutritional, and metabolic diseases – 18 codes. Included are codes for insulin resistance and hypoparathyroidism.

Chapter 6: Diseases of nervous system – 24 codes. There are new codes for Lafora Body Disease, or Lafora progressive myoclonus epilepsy, which is a neurodegenerative condition caused by a glycogen metabolism disorder that results in the accumulation of abnormal glycogen aggregates called Lafora Bodies in the brain, heart, and liver. Four codes are new for chronic migraine with aura, and five codes for Parkinson’s disease with/without dyskinesia, with/without fluctuations. Parkinson’s disease (PD) is a progressive neurodegenerative disease that presents with motor symptoms such as bradykinesia with muscle rigidity, tremor, and/or postural instability, as well as non-motor symptoms such as anxiety/panic attacks, problems with executive function, and pain.

Chapter 7: Diseases of eye and adnexa – 34 codes, including new codes for sickle-cell retinopathy, muscle entrapment by site, and foreign body sensations.

Chapter 9: Diseases of circulatory system – 10 codes. Codes include codes related to tachycardia, angina, and microvascular dysfunction.

Chapter 10: Diseases of respiratory system – 7 codes. Codes include pneumonia due to Acinetobacter baumannii and lung allograft dysfunction.

Chapter 11: Diseases of digestive system – 17 codes. New codes include acute appendicitis with generalized peritonitis, small intestinal bacterial or fungal overgrowth, and short bowel syndrome.

Chapter 13: Diseases of musculoskeletal system – 36 codes specific to osteoporosis of pelvis with pathological fracture.

Chapter 14: Diseases of genitourinary system – 15 codes including recurrent and persistent immunoglobulin A nephropathy (IgAN), the most common form of glomerulonephropathy.

Chapter 15: Pregnancy, childbirth, and puerperium – 6 codes, including new codes for intrahepatic cholestasis of pregnancy (ICP), a pregnancy-specific disorder where bile acid transport in the liver is altered. This leads to a build-up of bile acid in both the maternal circulation as well as the fetal amniotic fluid.

Chapter 17: Congenital malformations – 22 codes, including specific types of craniosynostosis.

Chapter 18: Symptoms, signs, and abnormal clinical and laboratory findings – 18 codes, including codes for foreign body sensation and breast density.

Chapter 19: Injury, Poisoning – 12 codes for the toxic effect of gadolinium.

Chapter 20: External causes of morbidity – 123 codes for objects entering through a natural orifice. Examples are buttons, batteries, plastic objects, jewelry, etc.

Chapter 21: Factors influencing health status and contact with health services – 30 codes. These codes include a variety of conditions such as carrier status, history codes, and codes related to Social Determinants of Health (SDOH). The new subcategory “Caregiver’s noncompliance with patient’s medical treatment and regimen” is an example.

Click HERE to refer to the details changes of ICD 10 CM codes 2024